1. Home
  2. Research
  3. Research Groups
  4. Multiple Sclerosis

Multiple Sclerosis

Search for publications

Only original articles, editorials, guidelines.

  • Frau J, Villar LM, Sardu C, Secci MA, Schirru L, Ferraro D, Coghe G, Lorefice L, Fenu G, Bedin R, Sola P, Marrosu MG, Cocco E.

    Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

    JOURNAL OF NEUROLOGY . 265(2): 424-430. Number of citations: 13

    [doi:10.1007/s00415-017-8716-4]

  • Alenda R, Costa-Frossard L, Alvarez-Lafuente R, Espejo C, Rodríguez-Martín E, Sainz de la Maza S, Villarrubia N, Río J, Domínguez-Mozo MI, Montalban X, Álvarez-Cermeño JC, Villar LM.

    Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

    JOURNAL OF NEUROLOGY . 265(1): 32-32.

    [doi:10.1007/s00415-017-8679-5]

  • Alenda R, Costa-Frossard L, Alvarez-Lafuente R, Espejo C, Rodríguez-Martín E, de la Maza SS, Villarrubia N, Río J, Domínguez-Mozo MI, Montalban X, Álvarez-Cermeño JC, Villar LM.

    Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

    JOURNAL OF NEUROLOGY . 265(1): 24-31. Number of citations: 10

    [doi:10.1007/s00415-017-8625-6]

  • Quintana E, Ortega FJ, Robles-Cedeño R, Villar ML, Buxó M, Mercader JM, Alvarez-Cermeño JC, Pueyo N, Perkal H, Fernández-Real JM, Ramió-Torrentà L.

    miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.

    MULTIPLE SCLEROSIS JOURNAL . 23(13): 1716-1726. Number of citations: 39

    [doi:10.1177/1352458516684213]

  • Fernández-Paredes L, Casrouge A, Decalf J, de Andrés C, Villar LM, Pérez de Diego R, Alonso B, Álvarez Cermeño JC, Arroyo R, Tejera-Alhambra M, Navarro J, Oreja-Guevara C, López Trascasa M, Seyfferth A, García Martínez MA, Álvarez Lafuente R, Albert ML, Sánchez-Ramón S.

    Multimarker risk stratification approach at multiple sclerosis onset.

    CLINICAL IMMUNOLOGY . 181: 43-50. Number of citations: 9

    [doi:10.1016/j.clim.2017.05.019]

  • Espiño M, Arteche-López A, Medina S, Muñoz-Calleja C, Blanchard MJ, Alegre A, López-Jiménez FJ, Villar LM.

    Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients.

    BONE MARROW TRANSPLANTATION . 52(8): 1206-1207. Number of citations: 1

    [doi:10.1038/bmt.2017.97]

  • Oleñik A, Gonzalo-Suárez B, Revenga M, Roldán E, Vázquez M, Muñoz-Negrete FJ.

    Use of Aqueous Humor and Flow Cytometry in Ocular Sarcoidosis Diagnosis.

    OCULAR IMMUNOLOGY AND INFLAMMATION . 25(4): 540-544. Number of citations: 1

    [doi:10.3109/09273948.2016.1158839]

  • Arteche-López A, Kreutzman A, Alegre A, Sanz Martín P, Aguado B, González-Pardo M, Espiño M, Villar LM, García Belmonte D, de la Cámara R, Muñoz-Calleja C.

    Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication.

    BONE MARROW TRANSPLANTATION . 52(6): 832-838. Number of citations: 18

    [doi:10.1038/bmt.2017.29]

  • Órpez-Zafra T, Pavía J, Hurtado-Guerrero I, Pinto-Medel MJ, Rodriguez Bada JL, Urbaneja P, Suardíaz M, Villar LM, Comabella M, Montalban X, Alvarez-Cermeño JC, Leyva L, Fernández Ó, Oliver-Martos B.

    Decreased soluble IFN-ß receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.

    MULTIPLE SCLEROSIS JOURNAL . 23(7): 937-945. Number of citations: 7

    [doi:10.1177/1352458516667564]

  • Carrillo-Salinas FJ, Mestre L, Mecha M, Feliú A, Del Campo R, Villarrubia N, Espejo C, Montalbán X, Álvarez-Cermeño JC, Villar LM, Guaza C.

    Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

    SCIENTIFIC REPORTS . 7: 44377-44377. Number of citations: 29

    [doi:10.1038/srep44377]

  • Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A.

    Metabolomic signatures associated with disease severity in multiple sclerosis.

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 4(2): .

    [doi:10.1212/NXI.0000000000000321]

  • Matute-Blanch C, Río J, Villar LM, Midaglia L, Malhotra S, Álvarez-Cermeño JC, Vidal-Jordana A, Montalban X, Comabella M.

    Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosis.

    JOURNAL OF NEUROIMMUNOLOGY . 303: 62-65. Number of citations: 12

    [doi:10.1016/j.jneuroim.2016.12.006]

  • Fernández-Pablos MA, Costa-Frossard L, García-Hernández C, García-Montes I, Escutia-Roig M, Grupo de enfermeras expertas en el manejo de los síntomas asociados a la espasti.

    Manejo de los síntomas asociados a la espasticidad en pacientes con esclerosis múltiple.

    ENFERMERIA CLINICA . 26(6): 367-373. Number of citations: 2

    [doi:10.1016/j.enfcli.2016.06.009]

  • Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cermeño JC, Picón C, Kuhle J, Disanto G, Kappos L, Sastre-Garriga J, Pareto D, Simon E, Comabella M, Río J, Nos C, Tur C, Castilló J, Vidal-Jordana A, Galán I, Arévalo MJ, Auger C, Rovira A, Montalban X, Tintore M.

    Neurofilament light chain level is a weak risk factor for the development of MS.

    Neurology . 87(11): 1076-1084. Number of citations: 66

    [doi:10.1212/WNL.0000000000003085]

  • Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antigüedad A, Vandenbroeck K, Akkad DA, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen JT, Gerdes LA, Kroner A, Kubisch C, Kümpfel T, Lohse P, Rieckmann P, Zettl UK, Zipp F, Bertram L, Lill CM, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeño JC, Arroyo R, Garagorri AM, García-Martínez A, Villar LM, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied MC, Zimprich A, Vilarino-Guell C.

    Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.

    G3-GENES GENOMES GENETICS . 6(7): 2073-2079. Number of citations: 8

    [doi:10.1534/g3.116.030841]

  • Fernandez O, Rodriguez-Antiguedad A, Olascoaga J, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Saiz A, Calles-Hernandez MC, Izquierdo G, Villar LM, Oliva-Nacarino P, Arnal-Garcia C, Comabella M, Brieva L, Arroyo R, Montalban X.

    Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting.

    REVISTA DE NEUROLOGIA . 62(12): 559-569. Number of citations: 8

    [doi:10.33588/rn.6212.2016196]

  • Sainz-de-la-Maza S, Casado JL, Pérez-Elías MJ, Moreno A, Quereda C, Moreno S, Corral I.

    Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

    EUROPEAN JOURNAL OF NEUROLOGY . 23(5): 919-925. Number of citations: 19

    [doi:10.1111/ene.12963]

  • Martínez-Rodríguez JE, Cobo-Calvo A, Villar LM, Munteis E, Blanco Y, Rasal R, Vera A, Muntasell A, Alvarez-Lafuente R, Saiz A, Alvarez-Cermeño JC, Martínez-Yélamos S, Roquer J, López-Botet M.

    Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis

    MULTIPLE SCLEROSIS JOURNAL . 22(6): 741-752. Number of citations: 16

    [doi:10.1177/1352458515601215]